NHS reimburses Roche's Hemlibra in new group of haemophilia ...

NHS England has agreed to reimburse Roche’s Hemlibra (emicizumab) in a new group of patients with haemophilia A, widening access to the potentially life-saving drug.

After two decades taking on pharma over price, Sir Andrew Di...

After more than 20 years of challenging pharma over drug prices, Sir Andrew Dillon is to step down as NICE’s chief executive next year.

Lilly faces biosimilar rivals to osteoporosis drug Forsteo i...

FDA says no to Sarepta's golodirsen, blocking bid to expand ...

AbbVie prices Rinvoq close to Humira after arthritis approva...

Scotland's cost regulator rejects Vertex cystic fibrosis dru...

Scotland’s cost-effectiveness body has rejected regular NHS funding for Vertex’s cystic fibrosis drugs Orkambi and Symkevi because of concerns about whether their high costs justify uncerta